Somewhat Critical Media Coverage Somewhat Likely to Impact Aspen Aerogels (ASPN) Stock Price
News articles about Aspen Aerogels (NYSE:ASPN) have trended somewhat negative on Saturday, according to AlphaOne Sentiment Analysis. AlphaOne, a unit of Accern, rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. AlphaOne ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Aspen Aerogels earned a daily sentiment score of -0.08 on AlphaOne’s scale. AlphaOne also gave news coverage about the construction company an impact score of 50 out of 100, meaning that recent news coverage is somewhat likely to have an impact on the stock’s share price in the near future.
ASPN has been the subject of several research reports. Zacks Investment Research cut shares of Aspen Aerogels from a “hold” rating to a “sell” rating in a research note on Tuesday, May 9th. Needham & Company LLC reduced their target price on shares of Aspen Aerogels from $8.00 to $6.00 and set a “buy” rating for the company in a research note on Friday, February 24th. Finally, Citigroup Inc. increased their target price on shares of Aspen Aerogels from $4.50 to $4.75 and gave the company a “neutral” rating in a research note on Tuesday, May 30th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and three have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $7.25.
Shares of Aspen Aerogels (NYSE:ASPN) traded down 1.23% on Friday, reaching $4.01. 42,988 shares of the company’s stock were exchanged. The company’s market cap is $82.53 million. The firm’s 50-day moving average price is $4.30 and its 200 day moving average price is $4.22. Aspen Aerogels has a 12 month low of $3.61 and a 12 month high of $6.71.
Aspen Aerogels (NYSE:ASPN) last announced its earnings results on Thursday, May 4th. The construction company reported ($0.39) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.29) by $0.10. Aspen Aerogels had a negative return on equity of 16.60% and a negative net margin of 17.89%. The business had revenue of $23 million for the quarter, compared to analyst estimates of $22.30 million. During the same quarter in the previous year, the company earned ($0.08) EPS. The business’s revenue for the quarter was down 29.9% on a year-over-year basis. Equities research analysts predict that Aspen Aerogels will post ($0.88) EPS for the current fiscal year.
In other Aspen Aerogels news, Director Robert M. Gervis bought 9,954 shares of the firm’s stock in a transaction on Thursday, April 13th. The shares were purchased at an average price of $3.99 per share, for a total transaction of $39,716.46. Following the transaction, the director now directly owns 63,207 shares in the company, valued at approximately $252,195.93. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Robert M. Gervis bought 7,912 shares of the firm’s stock in a transaction on Thursday, March 23rd. The shares were acquired at an average price of $3.95 per share, for a total transaction of $31,252.40. Following the transaction, the director now owns 54,486 shares in the company, valued at $215,219.70. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 103,230 shares of company stock worth $411,759. Company insiders own 14.70% of the company’s stock.
Aspen Aerogels Company Profile
Aspen Aerogels, Inc is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in energy infrastructure facilities. The Company also performs contract research services for various federal and non-federal government agencies, including the Department of Defense, the Department of Energy and other institutions.
Receive News & Ratings for Aspen Aerogels Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels Inc. and related companies with MarketBeat.com's FREE daily email newsletter.